• 1
    American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003; 54:141169.
  • 2
    National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: Breast cancer screening for women ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997; 89:10151026.
  • 3
    Smith RA. Breast cancer screening among women younger than age 50: A current assessment of the issues. CA Cancer J Clin 2000; 50:312336.
  • 4
    Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355:129134.
  • 5
    Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002: 359:909919.
  • 6
    Boyle P. Current situation of screening for cancer. Ann Oncol 2002; 13:189198.
  • 7
    Humphrey LL, Helfand M, Chan BK, et al. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347360.
  • 8
    Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138:168175.
  • 9
    Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913918.
  • 10
    Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997; 277:9971003.